A detailed history of Hemington Wealth Management transactions in Haemonetics Corp stock. As of the latest transaction made, Hemington Wealth Management holds 59 shares of HAE stock, worth $2,906. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59
Previous 52 13.46%
Holding current value
$2,906
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 24, 2025

BUY
$56.04 - $74.77 $392 - $523
7 Added 13.46%
59 $4,000
Q1 2025

May 09, 2025

BUY
$59.34 - $80.05 $1,661 - $2,241
28 Added 116.67%
52 $3,000
Q4 2024

Jan 29, 2025

BUY
$71.16 - $93.38 $640 - $840
9 Added 60.0%
24 $1,000
Q3 2024

Nov 12, 2024

BUY
$72.45 - $91.58 $1,086 - $1,373
15 New
15 $1,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $2.53B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Hemington Wealth Management Portfolio

Follow Hemington Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemington Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Hemington Wealth Management with notifications on news.